Preclinical Safety and Efficacy of Intein-Based Dual-AAV Gene Therapy for Stargardt Disease

被引：0
|
作者：
Vila-Perello, Miquel [1 ]
Di Scala, Marianna [1 ]
Aisa, Izarbe [1 ]
Abad, Victor [1 ]
Caelles, Gerard [1 ]
Esteve Rudd, Julian [1 ]
Frutos, Silvia [1 ]
Favre, David [1 ]
机构：
[1] SpliceBio, Barcelona, Spain
来源：
MOLECULAR THERAPY | 2024年 / 32卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
655
引用
收藏
页码：333 / 333
页数：1
相关论文
共 50 条
  • [21] Efficacy and Safety of a Krabbe Disease Gene Therapy
    Hordeaux, Juliette
    Jeffrey, Brianne A.
    Jian, Jinlong
    Choudhury, Gourav R.
    Michalson, Kristofer
    Mitchell, Thomas W.
    Buza, Elizabeth L.
    Chichester, Jessica
    Dyer, Cecilia
    Bagel, Jessica
    Vite, Charles H.
    Bradbury, Allison M.
    Wilson, James M.
    HUMAN GENE THERAPY, 2022, 33 (9-10) : 499 - 517
  • [22] Preclinical Safety Studies for AAV2-MerTK Gene Therapy Vector for Retinitis Pigmentosa
    Conlon, Thomas J.
    Deng, Wen-Tao
    Ryals, Renee C.
    Erger, Kirsten E.
    Cossette, Travis L.
    Boye, Shannon E.
    McDoom, Isaam
    Clemente, Nathalie
    Cleaver, Brian
    Potter, Mark
    Abernathy, Corinne
    Boye, Sanford L.
    Hauswirth, William W.
    MOLECULAR THERAPY, 2013, 21 : S23 - S23
  • [23] Preclinical Evidence of Long-term Efficacy and Safety of LX2020, an AAV based Plakophilin-2 Gene Therapy, for the Treatment of Arrhythmogenic Cardiomyopathy
    Zhang, Jing
    Lara, Erika Joana Gutierrez
    Do, Aryanne
    Nguyen, Lena
    Nair, Anju
    Selvan, Nithya
    Fenn, Tim
    Adler, Eric
    Khanna, Richie
    Sheikh, Farah
    CIRCULATION RESEARCH, 2024, 135
  • [24] Safety and Efficacy of EXG102-031, a Novel AAV-Based Gene Therapy for Neovascular AMD
    Wu, Zhenhua
    Dai, Li
    Song, Chunjuan
    Shen, Jikui
    Formica, Raquel
    Wang, Lijun
    Campochiaro, Peter A.
    Ye, Guo-Jie
    MOLECULAR THERAPY, 2023, 31 (04) : 545 - 545
  • [25] Preclinical efficacy and safety of lentiviral (LV)-based gene therapy in IMO support clinical trial initiation
    Moscatelli, Ilana
    Loefvall, Henrik
    Kohn, Donald
    Ricks, David
    Rothe, Michael
    Almarza, Elena
    Herzog, Chris
    Gutierrez, Sonia
    Law, Ken
    Nicoletti, Eileen
    Schambach, Axel
    Schwartz, Jonathan
    Richter, Johan
    JOURNAL OF BONE AND MINERAL RESEARCH, 2022, 37 : 196 - 196
  • [26] Preclinical efficacy and safety of lentiviral (LV)-based gene therapy in IMO support clinical trial initiation
    Moscatelli, I.
    Kohn, D. B.
    Ricks, D.
    Rothe, M.
    Almarza, E.
    Herzog, C.
    Gutierrez, S.
    Law, K. M.
    Nicoletti, E.
    Schambach, A.
    Schwartz, J.
    Richter, J.
    HUMAN GENE THERAPY, 2021, 32 (19-20) : A81 - A82
  • [27] Pre-clinical safety and efficacy of AT845, a muscle-directed AAV-based gene replacement therapy for Pompe disease
    Eggers, M.
    Vannoy, C.
    Huang, J.
    Purushottoman, P.
    Brassard, J.
    Gray, J.
    Lawlor, M.
    Sadhu, C.
    Mavilio, F.
    NEUROMUSCULAR DISORDERS, 2020, 30 : S48 - S49
  • [28] Long-term safety and efficacy of AAV gene therapy in the canine model of glycogen storage disease type Ia
    Lee, Young Mok
    Conlon, Thomas J.
    Specht, Andrew
    Coleman, Kirsten E.
    Brown, Laurie M.
    Estrella, Ana M.
    Dambska, Monika
    Dahlberg, Kathryn R.
    Weinstein, David A.
    JOURNAL OF INHERITED METABOLIC DISEASE, 2018, 41 (06) : 977 - 984
  • [29] The effect of a secretion-enhanced heavy chain on improving intein-based dual-vector co-delivery of a full-length factor Ⅷ gene
    ZHU FuXiang
    Science Bulletin, 2011, (02) : 158 - 163
  • [30] Safety, Toxicology and Efficacy of a Lung-Directed AAV-Based Gene Therapy for α1-Antitrypsin Deficiency
    Chiuchiolo, Maria J.
    Hackett, Neil R.
    Frenk, Esther Z.
    Hwang, Yihharn
    Qiu, Jianping
    Benson, Janet
    Wang, Gensheng
    Kaminsky, Stephen M.
    Crystal, Ronald G.
    MOLECULAR THERAPY, 2013, 21 : S43 - S44
12345